Your browser doesn't support javascript.
loading
Redistribution of body composition in patients with Graves' disease after iodine-131 treatment.
Xie, L-J; Zhou, H-J; Li, J-F; Zhang, F; Zeng, F-W; Qin, L-P; Chen, Y; Yuan, H-J; Cheng, M-H.
  • Xie LJ; Department of Nuclear Medicine, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou City, China.
  • Zhou HJ; Department of Internal Medicine, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou City, China.
  • Li JF; Department of Nuclear Medicine, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou City, China.
  • Zhang F; Department of Nuclear Medicine, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou City, China.
  • Zeng FW; Department of Nuclear Medicine, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou City, China.
  • Qin LP; Department of Nuclear Medicine, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou City, China.
  • Chen Y; Department of Nuclear Medicine, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou City, China.
  • Yuan HJ; Department of Nuclear Medicine, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou City, China.
  • Cheng MH; Department of Nuclear Medicine, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou City, China.
Eur J Clin Nutr ; 69(7): 856-61, 2015 Jul.
Article en En | MEDLINE | ID: mdl-25351654
OBJECTIVE: The objective of this study was to investigate body composition redistribution at 3 months after radioactive iodine therapy (RAI). METHODS: Eighty patients with Graves' disease (GD) for RAI and 18 volunteers were recruited. All patients underwent thyroid status test and dual-energy x-ray absorptiometry at baseline and 3 months after RAI. According to the second thyroid status test, patients were divided into the following groups: A, with aggravated hyperthyroidism; B-1, with improved hyperthyroidism; B-2, with euthyroidism; and B-3, with hypothyroidism. RESULTS: Total lean mass (LM) but fat mass (FM) and bone mineral content (BMC) of whole GD patients after RAI recovered to be not different with controls. Compared with baseline, in group A, FM in the left leg increased, and LM in left arm, right arm, trunk and total LM decreased (P<0.05). In B-2, FM in the head increased, and LM in the head, right arm, trunk and total LM increased (P<0.05). In B-3, FM in the right leg and total body fat percentage decreased, but FM in the head, android-to-gynoid fat ratio and body mass index increased (P<0.05); LM of all sites, weight and total mass increased (P<0.05); BMC in lumbar spine and left leg, and total BMC decreased (P<0.05). Body composition of unmentioned sites was retained after RAI in each group (P>0.05). CONCLUSIONS: Replenishment of LM gets priority rather than FM and BMC during the first 3 months after RAI, and the increase in LM starts from the upper body; head is the regional site in which FM recovery occurs first.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glándula Tiroides / Desarrollo Óseo / Enfermedad de Graves / Radiofármacos / Desarrollo de Músculos / Adiposidad / Radioisótopos de Yodo Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glándula Tiroides / Desarrollo Óseo / Enfermedad de Graves / Radiofármacos / Desarrollo de Músculos / Adiposidad / Radioisótopos de Yodo Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2015 Tipo del documento: Article